Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

ECMO bleeding mystery: could a clotting factor be the culprit?

NCT ID NCT03070912

First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 21 times

Summary

This study observed 257 emergency patients on ECMO (a heart-lung machine) to understand why many experience serious bleeding. Researchers checked if a defect in von Willebrand factor, a protein that helps blood clot, was related to these bleeds. The goal was to learn more about the causes of bleeding in these critically ill patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CH ARRAS

    Arras, France

  • CH Boulogne

    Boulogne-sur-Mer, France

  • CH DOUAI

    Douai, France

  • CH Dunkerque

    Dunkirk, 59385, France

  • Ch Tourcoing

    Tourcoing, France

  • Ch Valenciennes

    Valenciennes, France

  • Hôpital Cardiologie, CHU

    Lille, France

Conditions

Explore the condition pages connected to this study.